Cargando…

Paired genetic analysis by next‐generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis

The pathogenesis of lung cancer associated with idiopathic pulmonary fibrosis (IPF) has remained largely uncharacterized. To provide insight into this condition, we undertook genomic profiling of IPF‐associated lung cancer as well as of adjacent fibrosing lung tissue in surgical specimens. Isolated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsubo, Kohei, Iwama, Eiji, Ijichi, Kayo, Kubo, Naoki, Yoneshima, Yasuto, Inoue, Hiroyuki, Tanaka, Kentaro, Osoegawa, Atsushi, Tagawa, Tetsuzo, Nakanishi, Yoichi, Okamoto, Isamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385390/ https://www.ncbi.nlm.nih.gov/pubmed/32426915 http://dx.doi.org/10.1111/cas.14488

Ejemplares similares

Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer
por: Ando, Nobuhisa, et al.
Publicado: (2020)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis
por: Yoneshima, Yasuto, et al.
Publicado: (2021)

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade
por: Tanaka, Kentaro, et al.
Publicado: (2018)

(18)F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer
por: Takada, Kazuki, et al.
Publicado: (2019)

Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer
por: Iwama, Eiji, et al.
Publicado: (2023)

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2022)

Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
por: Okamura, Koji, et al.
Publicado: (2022)

Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β
por: Hirayama, Aiko, et al.
Publicado: (2023)

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2021)

MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
por: Nakanishi, Takayuki, et al.
Publicado: (2023)

Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor
por: Hino, Takuya, et al.
Publicado: (2019)

PICT1 expression is a poor prognostic factor in non-small cell lung cancer
por: Okamura, Kyoko, et al.
Publicado: (2014)

Recurrent idiopathic pulmonary hemosiderosis after long-term remission presented with Sjogren's syndrome: Idiopathic no more?
por: Yanagihara, Toyoshi, et al.
Publicado: (2018)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
por: Iwama, Eiji, et al.
Publicado: (2014)

Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancer
por: Ibusuki, Ritsu, et al.
Publicado: (2022)

IgG4-Related Lung Disease Exhibiting the Invasion into the Diaphragm: A Case Report
por: Ono, Yuki, et al.
Publicado: (2020)

HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors
por: Yoneshima, Yasuto, et al.
Publicado: (2020)

Visualization and quantitation of epidermal growth factor receptor homodimerization and activation with a proximity ligation assay
por: Ota, Keiichi, et al.
Publicado: (2017)

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations
por: Tanaka, Kentaro, et al.
Publicado: (2017)

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma
por: Takada, Kazuki, et al.
Publicado: (2019)

Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: A case report
por: Egashira, Ayaka, et al.
Publicado: (2023)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis
por: Ide, Maako, et al.
Publicado: (2018)

Spontaneous improvement of laryngeal sarcoidosis resistant to systemic corticosteroid administration
por: Tsubouchi, Kazuya, et al.
Publicado: (2015)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

A case of immunoglobulin G4-related respiratory disease with multiple lung cysts: A case report
por: Mikumo, Hironori, et al.
Publicado: (2017)

Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy
por: Takada, K., et al.
Publicado: (2021)

Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR
por: Iwama, Eiji, et al.
Publicado: (2015)

An autopsy case of bird-related chronic hypersensitivity pneumonitis presenting with repeated acute exacerbation
por: Mikumo, Hironori, et al.
Publicado: (2018)

Pulmonary metastasis presenting as a ground glass opacity-like lesion with a thin-walled cavity: A case report
por: Haro, Akira, et al.
Publicado: (2019)

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
por: Iwama, Eiji, et al.
Publicado: (2018)

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer
por: Otsubo, Kohei, et al.
Publicado: (2017)

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
por: Li, Heyan, et al.
Publicado: (2014)

Clinical significance of part-solid lung cancer in the eighth edition TNM staging system
por: Okamoto, Tatsuro, et al.
Publicado: (2021)

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors
por: Takada, Kazuki, et al.
Publicado: (2022)

Mycobacterium avium pleuritis with multiple nodules in the pleura
por: Ogata, Hiroaki, et al.
Publicado: (2020)

Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry
por: Tsubouchi, Kazuya, et al.
Publicado: (2023)

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma
por: Matsubara, Taichi, et al.
Publicado: (2019)

Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study
por: Kinoshita, Fumihiko, et al.
Publicado: (2021)

Sensitivity of epidermal growth factor receptor with single or double uncommon mutations to afatinib confirmed by a visual assay
por: Kimura, Shinichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o4h0a15bba98gqv63us8qlsbvm